Copyright Reports & Markets. All rights reserved.

Global Injectable Cosmetic Facial Product Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Injectable Cosmetic Facial Product
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Injectable Cosmetic Facial Product by Type
    • 1.3.1 Overview: Global Injectable Cosmetic Facial Product Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Injectable Cosmetic Facial Product Consumption Value Market Share by Type in 2022
    • 1.3.3 Dermal Fillers
    • 1.3.4 Botulinum Toxin
    • 1.3.5 Other
  • 1.4 Global Injectable Cosmetic Facial Product Market by Application
    • 1.4.1 Overview: Global Injectable Cosmetic Facial Product Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Hospital
    • 1.4.3 Beauty Salon
    • 1.4.4 Other
  • 1.5 Global Injectable Cosmetic Facial Product Market Size & Forecast
  • 1.6 Global Injectable Cosmetic Facial Product Market Size and Forecast by Region
    • 1.6.1 Global Injectable Cosmetic Facial Product Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Injectable Cosmetic Facial Product Market Size by Region, (2018-2029)
    • 1.6.3 North America Injectable Cosmetic Facial Product Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Injectable Cosmetic Facial Product Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Injectable Cosmetic Facial Product Market Size and Prospect (2018-2029)
    • 1.6.6 South America Injectable Cosmetic Facial Product Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Injectable Cosmetic Facial Product Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 AbbVie
    • 2.1.1 AbbVie Details
    • 2.1.2 AbbVie Major Business
    • 2.1.3 AbbVie Injectable Cosmetic Facial Product Product and Solutions
    • 2.1.4 AbbVie Injectable Cosmetic Facial Product Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 AbbVie Recent Developments and Future Plans
  • 2.2 Galderma
    • 2.2.1 Galderma Details
    • 2.2.2 Galderma Major Business
    • 2.2.3 Galderma Injectable Cosmetic Facial Product Product and Solutions
    • 2.2.4 Galderma Injectable Cosmetic Facial Product Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Galderma Recent Developments and Future Plans
  • 2.3 LG Life Sciences
    • 2.3.1 LG Life Sciences Details
    • 2.3.2 LG Life Sciences Major Business
    • 2.3.3 LG Life Sciences Injectable Cosmetic Facial Product Product and Solutions
    • 2.3.4 LG Life Sciences Injectable Cosmetic Facial Product Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 LG Life Sciences Recent Developments and Future Plans
  • 2.4 Merz
    • 2.4.1 Merz Details
    • 2.4.2 Merz Major Business
    • 2.4.3 Merz Injectable Cosmetic Facial Product Product and Solutions
    • 2.4.4 Merz Injectable Cosmetic Facial Product Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Merz Recent Developments and Future Plans
  • 2.5 Medytox
    • 2.5.1 Medytox Details
    • 2.5.2 Medytox Major Business
    • 2.5.3 Medytox Injectable Cosmetic Facial Product Product and Solutions
    • 2.5.4 Medytox Injectable Cosmetic Facial Product Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Medytox Recent Developments and Future Plans
  • 2.6 Hugel
    • 2.6.1 Hugel Details
    • 2.6.2 Hugel Major Business
    • 2.6.3 Hugel Injectable Cosmetic Facial Product Product and Solutions
    • 2.6.4 Hugel Injectable Cosmetic Facial Product Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Hugel Recent Developments and Future Plans
  • 2.7 Croma-Pharma
    • 2.7.1 Croma-Pharma Details
    • 2.7.2 Croma-Pharma Major Business
    • 2.7.3 Croma-Pharma Injectable Cosmetic Facial Product Product and Solutions
    • 2.7.4 Croma-Pharma Injectable Cosmetic Facial Product Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Croma-Pharma Recent Developments and Future Plans
  • 2.8 Beijing IMEIK
    • 2.8.1 Beijing IMEIK Details
    • 2.8.2 Beijing IMEIK Major Business
    • 2.8.3 Beijing IMEIK Injectable Cosmetic Facial Product Product and Solutions
    • 2.8.4 Beijing IMEIK Injectable Cosmetic Facial Product Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Beijing IMEIK Recent Developments and Future Plans
  • 2.9 Bloomage Bio
    • 2.9.1 Bloomage Bio Details
    • 2.9.2 Bloomage Bio Major Business
    • 2.9.3 Bloomage Bio Injectable Cosmetic Facial Product Product and Solutions
    • 2.9.4 Bloomage Bio Injectable Cosmetic Facial Product Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Bloomage Bio Recent Developments and Future Plans
  • 2.10 Elravie (Humedix)
    • 2.10.1 Elravie (Humedix) Details
    • 2.10.2 Elravie (Humedix) Major Business
    • 2.10.3 Elravie (Humedix) Injectable Cosmetic Facial Product Product and Solutions
    • 2.10.4 Elravie (Humedix) Injectable Cosmetic Facial Product Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Elravie (Humedix) Recent Developments and Future Plans
  • 2.11 Cleviel (Pharma Research Products)
    • 2.11.1 Cleviel (Pharma Research Products) Details
    • 2.11.2 Cleviel (Pharma Research Products) Major Business
    • 2.11.3 Cleviel (Pharma Research Products) Injectable Cosmetic Facial Product Product and Solutions
    • 2.11.4 Cleviel (Pharma Research Products) Injectable Cosmetic Facial Product Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Cleviel (Pharma Research Products) Recent Developments and Future Plans
  • 2.12 Haohai Biological
    • 2.12.1 Haohai Biological Details
    • 2.12.2 Haohai Biological Major Business
    • 2.12.3 Haohai Biological Injectable Cosmetic Facial Product Product and Solutions
    • 2.12.4 Haohai Biological Injectable Cosmetic Facial Product Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Haohai Biological Recent Developments and Future Plans
  • 2.13 Teoxane
    • 2.13.1 Teoxane Details
    • 2.13.2 Teoxane Major Business
    • 2.13.3 Teoxane Injectable Cosmetic Facial Product Product and Solutions
    • 2.13.4 Teoxane Injectable Cosmetic Facial Product Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Teoxane Recent Developments and Future Plans
  • 2.14 Sinclair
    • 2.14.1 Sinclair Details
    • 2.14.2 Sinclair Major Business
    • 2.14.3 Sinclair Injectable Cosmetic Facial Product Product and Solutions
    • 2.14.4 Sinclair Injectable Cosmetic Facial Product Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 Sinclair Recent Developments and Future Plans
  • 2.15 Suneva Medical
    • 2.15.1 Suneva Medical Details
    • 2.15.2 Suneva Medical Major Business
    • 2.15.3 Suneva Medical Injectable Cosmetic Facial Product Product and Solutions
    • 2.15.4 Suneva Medical Injectable Cosmetic Facial Product Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 Suneva Medical Recent Developments and Future Plans
  • 2.16 CG Bio
    • 2.16.1 CG Bio Details
    • 2.16.2 CG Bio Major Business
    • 2.16.3 CG Bio Injectable Cosmetic Facial Product Product and Solutions
    • 2.16.4 CG Bio Injectable Cosmetic Facial Product Revenue, Gross Margin and Market Share (2018-2023)
    • 2.16.5 CG Bio Recent Developments and Future Plans
  • 2.17 SciVision Biotech
    • 2.17.1 SciVision Biotech Details
    • 2.17.2 SciVision Biotech Major Business
    • 2.17.3 SciVision Biotech Injectable Cosmetic Facial Product Product and Solutions
    • 2.17.4 SciVision Biotech Injectable Cosmetic Facial Product Revenue, Gross Margin and Market Share (2018-2023)
    • 2.17.5 SciVision Biotech Recent Developments and Future Plans
  • 2.18 Prollenium
    • 2.18.1 Prollenium Details
    • 2.18.2 Prollenium Major Business
    • 2.18.3 Prollenium Injectable Cosmetic Facial Product Product and Solutions
    • 2.18.4 Prollenium Injectable Cosmetic Facial Product Revenue, Gross Margin and Market Share (2018-2023)
    • 2.18.5 Prollenium Recent Developments and Future Plans
  • 2.19 Bohus BioTech
    • 2.19.1 Bohus BioTech Details
    • 2.19.2 Bohus BioTech Major Business
    • 2.19.3 Bohus BioTech Injectable Cosmetic Facial Product Product and Solutions
    • 2.19.4 Bohus BioTech Injectable Cosmetic Facial Product Revenue, Gross Margin and Market Share (2018-2023)
    • 2.19.5 Bohus BioTech Recent Developments and Future Plans
  • 2.20 Caregen
    • 2.20.1 Caregen Details
    • 2.20.2 Caregen Major Business
    • 2.20.3 Caregen Injectable Cosmetic Facial Product Product and Solutions
    • 2.20.4 Caregen Injectable Cosmetic Facial Product Revenue, Gross Margin and Market Share (2018-2023)
    • 2.20.5 Caregen Recent Developments and Future Plans
  • 2.21 Ipsen
    • 2.21.1 Ipsen Details
    • 2.21.2 Ipsen Major Business
    • 2.21.3 Ipsen Injectable Cosmetic Facial Product Product and Solutions
    • 2.21.4 Ipsen Injectable Cosmetic Facial Product Revenue, Gross Margin and Market Share (2018-2023)
    • 2.21.5 Ipsen Recent Developments and Future Plans
  • 2.22 LIBP
    • 2.22.1 LIBP Details
    • 2.22.2 LIBP Major Business
    • 2.22.3 LIBP Injectable Cosmetic Facial Product Product and Solutions
    • 2.22.4 LIBP Injectable Cosmetic Facial Product Revenue, Gross Margin and Market Share (2018-2023)
    • 2.22.5 LIBP Recent Developments and Future Plans
  • 2.23 US World Meds
    • 2.23.1 US World Meds Details
    • 2.23.2 US World Meds Major Business
    • 2.23.3 US World Meds Injectable Cosmetic Facial Product Product and Solutions
    • 2.23.4 US World Meds Injectable Cosmetic Facial Product Revenue, Gross Margin and Market Share (2018-2023)
    • 2.23.5 US World Meds Recent Developments and Future Plans
  • 2.24 Daewoong
    • 2.24.1 Daewoong Details
    • 2.24.2 Daewoong Major Business
    • 2.24.3 Daewoong Injectable Cosmetic Facial Product Product and Solutions
    • 2.24.4 Daewoong Injectable Cosmetic Facial Product Revenue, Gross Margin and Market Share (2018-2023)
    • 2.24.5 Daewoong Recent Developments and Future Plans
  • 2.25 JETEMA
    • 2.25.1 JETEMA Details
    • 2.25.2 JETEMA Major Business
    • 2.25.3 JETEMA Injectable Cosmetic Facial Product Product and Solutions
    • 2.25.4 JETEMA Injectable Cosmetic Facial Product Revenue, Gross Margin and Market Share (2018-2023)
    • 2.25.5 JETEMA Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Injectable Cosmetic Facial Product Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Injectable Cosmetic Facial Product by Company Revenue
    • 3.2.2 Top 3 Injectable Cosmetic Facial Product Players Market Share in 2022
    • 3.2.3 Top 6 Injectable Cosmetic Facial Product Players Market Share in 2022
  • 3.3 Injectable Cosmetic Facial Product Market: Overall Company Footprint Analysis
    • 3.3.1 Injectable Cosmetic Facial Product Market: Region Footprint
    • 3.3.2 Injectable Cosmetic Facial Product Market: Company Product Type Footprint
    • 3.3.3 Injectable Cosmetic Facial Product Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Injectable Cosmetic Facial Product Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Injectable Cosmetic Facial Product Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global Injectable Cosmetic Facial Product Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global Injectable Cosmetic Facial Product Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America Injectable Cosmetic Facial Product Consumption Value by Type (2018-2029)
  • 6.2 North America Injectable Cosmetic Facial Product Consumption Value by Application (2018-2029)
  • 6.3 North America Injectable Cosmetic Facial Product Market Size by Country
    • 6.3.1 North America Injectable Cosmetic Facial Product Consumption Value by Country (2018-2029)
    • 6.3.2 United States Injectable Cosmetic Facial Product Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Injectable Cosmetic Facial Product Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Injectable Cosmetic Facial Product Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Injectable Cosmetic Facial Product Consumption Value by Type (2018-2029)
  • 7.2 Europe Injectable Cosmetic Facial Product Consumption Value by Application (2018-2029)
  • 7.3 Europe Injectable Cosmetic Facial Product Market Size by Country
    • 7.3.1 Europe Injectable Cosmetic Facial Product Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Injectable Cosmetic Facial Product Market Size and Forecast (2018-2029)
    • 7.3.3 France Injectable Cosmetic Facial Product Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Injectable Cosmetic Facial Product Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Injectable Cosmetic Facial Product Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Injectable Cosmetic Facial Product Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Injectable Cosmetic Facial Product Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Injectable Cosmetic Facial Product Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific Injectable Cosmetic Facial Product Market Size by Region
    • 8.3.1 Asia-Pacific Injectable Cosmetic Facial Product Consumption Value by Region (2018-2029)
    • 8.3.2 China Injectable Cosmetic Facial Product Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Injectable Cosmetic Facial Product Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Injectable Cosmetic Facial Product Market Size and Forecast (2018-2029)
    • 8.3.5 India Injectable Cosmetic Facial Product Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Injectable Cosmetic Facial Product Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Injectable Cosmetic Facial Product Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Injectable Cosmetic Facial Product Consumption Value by Type (2018-2029)
  • 9.2 South America Injectable Cosmetic Facial Product Consumption Value by Application (2018-2029)
  • 9.3 South America Injectable Cosmetic Facial Product Market Size by Country
    • 9.3.1 South America Injectable Cosmetic Facial Product Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Injectable Cosmetic Facial Product Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Injectable Cosmetic Facial Product Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Injectable Cosmetic Facial Product Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Injectable Cosmetic Facial Product Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa Injectable Cosmetic Facial Product Market Size by Country
    • 10.3.1 Middle East & Africa Injectable Cosmetic Facial Product Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Injectable Cosmetic Facial Product Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Injectable Cosmetic Facial Product Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Injectable Cosmetic Facial Product Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Injectable Cosmetic Facial Product Market Drivers
  • 11.2 Injectable Cosmetic Facial Product Market Restraints
  • 11.3 Injectable Cosmetic Facial Product Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry
  • 11.5 Influence of COVID-19 and Russia-Ukraine War
    • 11.5.1 Influence of COVID-19
    • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

  • 12.1 Injectable Cosmetic Facial Product Industry Chain
  • 12.2 Injectable Cosmetic Facial Product Upstream Analysis
  • 12.3 Injectable Cosmetic Facial Product Midstream Analysis
  • 12.4 Injectable Cosmetic Facial Product Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Injectable Cosmetic Facial Product market size was valued at USD 13910 million in 2022 and is forecast to a readjusted size of USD 26690 million by 2029 with a CAGR of 9.8% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
    Injectable Cosmetic Facial Product refer to a range of aesthetic treatments that can enhance or rejuvenate the appearance of the face without the need for surgery. These procedures have gained popularity due to their non-invasive nature, minimal downtime, and ability to provide noticeable results.
    This report is a detailed and comprehensive analysis for global Injectable Cosmetic Facial Product market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
    Key Features:
    Global Injectable Cosmetic Facial Product market size and forecasts, in consumption value ($ Million), 2018-2029
    Global Injectable Cosmetic Facial Product market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
    Global Injectable Cosmetic Facial Product market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
    Global Injectable Cosmetic Facial Product market shares of main players, in revenue ($ Million), 2018-2023
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Injectable Cosmetic Facial Product
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Injectable Cosmetic Facial Product market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie, Galderma, LG Life Sciences, Merz and Medytox, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
    Market segmentation
    Injectable Cosmetic Facial Product market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Dermal Fillers
    Botulinum Toxin
    Other
    Market segment by Application
    Hospital
    Beauty Salon
    Other
    Market segment by players, this report covers
    AbbVie
    Galderma
    LG Life Sciences
    Merz
    Medytox
    Hugel
    Croma-Pharma
    Beijing IMEIK
    Bloomage Bio
    Elravie (Humedix)
    Cleviel (Pharma Research Products)
    Haohai Biological
    Teoxane
    Sinclair
    Suneva Medical
    CG Bio
    SciVision Biotech
    Prollenium
    Bohus BioTech
    Caregen
    Ipsen
    LIBP
    US World Meds
    Daewoong
    JETEMA
    Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Injectable Cosmetic Facial Product product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Injectable Cosmetic Facial Product, with revenue, gross margin and global market share of Injectable Cosmetic Facial Product from 2018 to 2023.
    Chapter 3, the Injectable Cosmetic Facial Product competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Injectable Cosmetic Facial Product market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
    Chapter 12, the key raw materials and key suppliers, and industry chain of Injectable Cosmetic Facial Product.
    Chapter 13, to describe Injectable Cosmetic Facial Product research findings and conclusion.

    Buy now